Neuro-Oncology Reviews

Volume 25 Number 23
15 December 2023

Home > Publications > Neuro-Oncology Reviews > Volume 25, Year 2023 > Number 23, 15 December

Olatunji G, Aderinto N, Adefusi T, Kokori E, Akinmoju O, Yusuf I, Olusakin T, Muzammil MA.
Efficacy of tumour-treating fields therapy in recurrent glioblastoma: A narrative review of current evidence.
Medicine (Baltimore). 2023 Dec 1;102(48):e36421. doi: 10.1097/MD.0000000000036421. PMID: 38050252. Review.

Weyer MP, Strehle J, Schäfer MKE, Tegeder I.
Repurposing of pexidartinib for microglia depletion and renewal.
Pharmacol Ther. 2023 Dec 3:108565. doi: 10.1016/j.pharmthera.2023.108565. PMID: 38052308. Review.

Dean L, Kane M.
Dabrafenib Therapy and BRAF Genotype.
Med Gen Summ. 2023 Dec 4. Bookshelf ID: NBK447415. PMID: 28809523. Review.

Maccari M, Baek C, Caccese M, Mandruzzato S, Fiorentino A, Internò V, Bosio A, Cerretti G, Padovan M, Idbaih A, Lombardi G.
Present and Future of Immunotherapy in Patients With Glioblastoma: Limitations and Opportunities.
Oncologist. 2023 Dec 4:oyad321. doi: 10.1093/oncolo/oyad321. PMID: 38048782. Review.

Onyije FM, Dolatkhah R, Olsson A, Bouaoun L, Deltour I, Erdmann F, Bonaventure A, Scheurer ME, Clavel J, Schüz J.
Risk factors for childhood brain tumours: A systematic review and meta-analysis of observational studies from 1976 to 2022.
Cancer Epidemiol. 2023 Dec 5;88:102510. doi: 10.1016/j.canep.2023.102510. PMID: 38056243. Review, Meta-analysis.

Wang Y, Xu C, Zhang Z.
Prognostic value of pretreatment lymphocyte-to-monocyte ratio in patients with glioma: a meta-analysis.
BMC Med. 2023 Dec 5;21(1):486. doi: 10.1186/s12916-023-03199-6. PMID: 38053096. Meta-analysis.

Castello A, Albano D, Muoio B, Castellani M, Panareo S, Rizzo A, Treglia G, Urso L.
Diagnostic Accuracy of PET with 18F-Fluciclovine ([18F]FACBC) in Detecting High-Grade Gliomas: A Systematic Review and Meta-Analysis.
Diagnostics (Basel). 2023 Dec 6;13(24):3610. doi: 10.3390/diagnostics13243610. PMID: 38132194. Review, Meta-Analysis.

Di Salle G, Tumminello L, Laino ME, Shalaby S, Aghakhanyan G, Fanni SC, Febi M, Shortrede JE, Miccoli M, Faggioni L, Cosottini M, Neri E.
Accuracy of Radiomics in Predicting IDH Mutation Status in Diffuse Gliomas: A Bivariate Meta-Analysis.
Radiol Artif Intell. 2023 Dec 6;6(1):e220257. doi: 10.1148/ryai.220257. PMID: 38231039. Meta-analysis. ˍ

Ge X, Yang Y, Wang W, Tian L, Zhang G, Tian Z, Xue X.
Pediatric H3K27M-mutant diffuse midline glioma with vertebral metastasis: A case report and literature review.
Oncol Lett. 2023 Dec 7;27(2):48. doi: 10.3892/ol.2023.14181. PMID: 38192660. Case report, Review. ˍ

Tangsiri M, Hheidari A, Liaghat M, Razlansari M, Ebrahimi N, Akbari A, Varnosfaderani SMN, Maleki-Sheikhabadi F, Norouzi A, Bakhtiyari M, Zalpoor H, Nabi-Afjadi M, Rahdar A.
Promising applications of nanotechnology in inhibiting chemo-resistance in solid tumors by targeting epithelial-mesenchymal transition (EMT).
Biomed Pharmacother. 2023 Dec 7;170:115973. doi: 10.1016/j.biopha.2023.115973. PMID: 38064969. Review.

Chang CT, Chen HH, Chuang CC, Chang SH, Hsiao NW.
Ganciclovir as a potential treatment for glioma: a systematic review and meta-analysis.
J Neurooncol. 2023 Dec 8. doi: 10.1007/s11060-023-04503-3. PMID: 38066255. Review, Meta-analysis˰ ˍ

Teng M, Wang M, He F, Liang W, Zhang G.
Arterial spin labeling and amide proton transfer imaging can differentiate glioblastoma from brain metastasis: a systematic review and meta-analysis.
World Neurosurg. 2023 Dec 8:S1878-8750(23)01744-8. doi: 10.1016/j.wneu.2023.12.023. PMID: 38072160. Review, Meta-analysis˰

Wu J, Heidelberg RE, Gajjar A.
Adolescents and Young Adults With Cancer: CNS Tumors.
J Clin Oncol. 2023 Dec 8:JCO2301747. doi: 10.1200/JCO.23.01747. PMID: 38064656. Review˰


Toader C, Eva L, Costea D, Corlatescu AD, Covache-Busuioc RA, Bratu BG, Glavan LA, Costin HP, Popa AA, Ciurea AV.
Low-Grade Gliomas: Histological Subtypes, Molecular Mechanisms, and Treatment Strategies.
Brain Sci. 2023 Dec 9;13(12):1700. doi: 10.3390/brainsci13121700. PMID: 38137148. Review.

Ahmedna T, Khela H, Weber-Levine C, Azad TD, Jackson CM, Gabrielson K, Bettegowda C, Rincon-Torroella J.
The Role of γδ T-Lymphocytes in Glioblastoma: Current Trends and Future Directions.
Cancers (Basel). 2023 Dec 10;15(24):5784. doi: 10.3390/cancers15245784. PMID: 38136330. Review.

Bhattacharya K, Rastogi S, Mahajan A.
Post-treatment imaging of gliomas: challenging the existing dogmas.
Clin Radiol. 2023 Dec 10:S0009-9260(23)00570-6. doi: 10.1016/j.crad.2023.11.017. PMID: 38123395. Review˰

Byrne EM, Pascoe M, Cooper D, Armstrong TS, Gilbert MR.
Challenges and limitations of clinical trials in the adolescent and young adult CNS cancer population: A systematic review.
Neurooncol Adv. 2023 Dec 10;6(1):vdad159. doi: 10.1093/noajnl/vdad159. PMID: 38250563. Review. ˍ

Satgunaseelan L, Sy J, Shivalingam B, Sim HW, Alexander KL, Buckland ME.
Prognostic and predictive biomarkers in central nervous system tumours: the molecular state of play.
Pathology. 2023 Dec 12:S0031-3025(23)00313-6. doi: 10.1016/j.pathol.2023.11.003. PMID: 38233331. Review˰ ˍ

Borni M, Abdelmouleh S, Tallah M, Blibeche H, Elouni E, Boudawara MZ.
Extra-axial desmoplastic/nodular medulloblastoma in adult mimicking cerebellar metastasis: reappraisal of this rare presentation with literature review.
Ann Med Surg (Lond). 2023 Dec 13;86(2):1124-1130. doi: 10.1097/MS9.0000000000001617. PMID: 38333306. Case report, Review. ˍ

Sanvito F, Kaufmann TJ, Cloughesy TF, Wen PY, Ellingson BM.
Standardized brain tumor imaging protocols for clinical trials: current recommendations and tips for integration.
Front Radiol. 2023 Dec 13;3:1267615. doi: 10.3389/fradi.2023.1267615. PMID: 38152383. Review.


Du Y, Pollok KE, Shen J.
Unlocking Glioblastoma Secrets: Natural Killer Cell Therapy against Cancer Stem Cells.
Cancers (Basel). 2023 Dec 14;15(24):5836. doi: 10.3390/cancers15245836. PMID: 38136381. Review.

Mistry AM.
Perioperative dexamethasone in high-grade gliomas: the short-term benefits and long-term harms.
Front Oncol. 2023 Dec 14;13:1335730. doi: 10.3389/fonc.2023.1335730. PMID: 38162484. Perspective. ˍ

Na B, Shah S, Nghiemphu PL.
Cancer Predisposition Syndromes in Neuro-Oncology.
Semin Neurol. 2023 Dec 14. doi: 10.1055/s-0043-1777702. PMID: 38096910. Review˰

Nakhate V, Gonzalez Castro LN.
Artificial intelligence in neuro-oncology.
Front Neurosci. 2023 Dec 14;17:1217629. doi: 10.3389/fnins.2023.1217629. PMID: 38161802. Review. ˍ

Patel J, Aittaleb R, Doherty R, Gera A, Lau B, Messinger D, Wadden J, Franson A, Saratsis A, Koschmann C.
Liquid Biopsy in H3K27M Diffuse Midline Glioma.
Neuro Oncol. 2023 Dec 14:noad229. doi: 10.1093/neuonc/noad229. PMID: 38096156. Review.

Rammeloo E, Schouten JW, Krikour K, Bos EM, Berger MS, Nahed BV, Vincent AJPE, Gerritsen JKW.
Preoperative assessment of eloquence in neurosurgery: a systematic review.
J Neurooncol. 2023 Dec 14. doi: 10.1007/s11060-023-04509-x. PMID: 38095774. Review˰

Reznicek J, Sharifai N, Jamshidi P, Wadhwani N, Ahrendsen JT.
Embryonal and pineal tumours.
Cytopathology. 2023 Dec 15. doi: 10.1111/cyt.13350. PMID: 38100134. Review.

Thenuwara G, Curtin J, Tian F.
Advances in Diagnostic Tools and Therapeutic Approaches for Gliomas: A Comprehensive Review.
Sensors (Basel). 2023 Dec 15;23(24):9842. doi: 10.3390/s23249842. PMID: 38139688. Review.

van den Bent M, Saratsis AM, Geurts M, Franceschi E.
H3 K27M-altered Glioma and Diffuse Intrinsic Pontine Glioma: Semi-systematic Review of Treatment Landscape and Future Directions.
Neuro Oncol. 2023 Dec 15:noad220∟. doi: 10.1093/neuonc/noad220∟. PMID: 38102230∟. Review.

Yu C, Hsieh K, Cherry DR, Nehlsen AD, Resende Salgado L, Lazarev S, Sindhu KK.
Immune Escape in Glioblastoma: Mechanisms of Action and Implications for Immune Checkpoint Inhibitors and CAR T-Cell Therapy.
Biology (Basel). 2023 Dec 15;12(12):1528. doi: 10.3390/biology12121528. PMID: 38132354. Review.